A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer
about
A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer
description
scientific article published on 25 May 2020
@en
wetenschappelijk artikel
@nl
name
A Triple Combination of Metfor ...... Triple-Negative Breast Cancer
@en
A Triple Combination of Metfor ...... Triple-Negative Breast Cancer
@nl
type
label
A Triple Combination of Metfor ...... Triple-Negative Breast Cancer
@en
A Triple Combination of Metfor ...... Triple-Negative Breast Cancer
@nl
prefLabel
A Triple Combination of Metfor ...... Triple-Negative Breast Cancer
@en
A Triple Combination of Metfor ...... Triple-Negative Breast Cancer
@nl
P2093
P50
P356
P1476
A Triple Combination of Metfor ...... Triple-Negative Breast Cancer
@en
P2093
Elena Markvicheva
Manpreet Sambi
Vanessa Samuel
William Harless
P304
P356
10.2147/DDDT.S242514
P577
2020-05-25T00:00:00Z